A study comparing ivonescimab and pembrolizumab in combination with enfortumab vedotin in previously untreated locally advanced or metastatic urothelial cancer

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: 24edeea5ebf62aec7e8a295fe43efb9a9cb89c69
First added on: Nov 01, 2026